Hite Hedge Asset Management LLC Intra Cellular Therapies, Inc. Transaction History

Hite Hedge Asset Management LLC

  • $971 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$23.34 - $32.22 $224,624 - $310,085
-9,624 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$14.35 - $26.64 $138,104 - $256,383
9,624 New
9,624 $247,000
Q1 2020

May 14, 2020
SELL
$12.31 - $33.12 $333,022 - $895,995
-27,053 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.26 - $38.49 $196,404 - $1.04 Million
27,053 New
27,053 $928,000

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
77.7M
Call Options Held
1.7M
Put Options Held
1.13M
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.47B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Hite Hedge Asset Management LLC Portfolio

Follow Hite Hedge Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hite Hedge Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hite Hedge Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email